Cargando…

Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes

OBJECTIVE— We examined the effect of the vasoactive agents carbon monoxide (CO) and nitric oxide (NO) on the phosphorylation and intracellular redistribution of vasodilator-stimulated phosphoprotein (VASP), a critical actin motor protein required for cell migration that also controls vasodilation an...

Descripción completa

Detalles Bibliográficos
Autores principales: Li Calzi, Sergio, Purich, Daniel L., Chang, Kyung Hee, Afzal, Aqeela, Nakagawa, Takahiko, Busik, Julia V., Agarwal, Anupam, Segal, Mark S., Grant, Maria B.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518501/
https://www.ncbi.nlm.nih.gov/pubmed/18559661
http://dx.doi.org/10.2337/db08-0381
_version_ 1782158579069878272
author Li Calzi, Sergio
Purich, Daniel L.
Chang, Kyung Hee
Afzal, Aqeela
Nakagawa, Takahiko
Busik, Julia V.
Agarwal, Anupam
Segal, Mark S.
Grant, Maria B.
author_facet Li Calzi, Sergio
Purich, Daniel L.
Chang, Kyung Hee
Afzal, Aqeela
Nakagawa, Takahiko
Busik, Julia V.
Agarwal, Anupam
Segal, Mark S.
Grant, Maria B.
author_sort Li Calzi, Sergio
collection PubMed
description OBJECTIVE— We examined the effect of the vasoactive agents carbon monoxide (CO) and nitric oxide (NO) on the phosphorylation and intracellular redistribution of vasodilator-stimulated phosphoprotein (VASP), a critical actin motor protein required for cell migration that also controls vasodilation and platelet aggregation. RESEARCH DESIGN AND METHODS— We examined the effect of donor-released CO and NO in endothelial progenitor cells (EPCs) and platelets from nondiabetic and diabetic subjects and in human microvascular endothelial cells (HMECs) cultured under low (5.5 mmol/l) or high (25 mmol/l) glucose conditions. VASP phosphorylation was evaluated using phosphorylation site-specific antibodies. RESULTS— In control platelets, CO selectively promotes phosphorylation at VASP Ser-157, whereas NO promotes phosphorylation primarily at Ser-157 and also at Ser-239, with maximal responses at 1 min with both agents on Ser-157 and at 15 min on Ser-239 with NO treatment. In diabetic platelets, neither agent resulted in VASP phosphorylation. In nondiabetic EPCs, NO and CO increased phosphorylation at Ser-239 and Ser-157, respectively, but this response was markedly reduced in diabetic EPCs. In endothelial cells cultured under low glucose conditions, both CO and NO induced phosphorylation at Ser-157 and Ser-239; however, this response was completely lost when cells were cultured under high glucose conditions. In control EPCs and in HMECs exposed to low glucose, VASP was redistributed to filopodia-like structures following CO or NO exposure; however, redistribution was dramatically attenuated under high glucose conditions. CONCLUSIONS— Vasoactive gases CO and NO promote cytoskeletal changes through site- and cell type–specific VASP phosphorylation, and in diabetes, blunted responses to these agents may lead to reduced vascular repair and tissue perfusion.
format Text
id pubmed-2518501
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-25185012009-09-01 Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes Li Calzi, Sergio Purich, Daniel L. Chang, Kyung Hee Afzal, Aqeela Nakagawa, Takahiko Busik, Julia V. Agarwal, Anupam Segal, Mark S. Grant, Maria B. Diabetes Complications OBJECTIVE— We examined the effect of the vasoactive agents carbon monoxide (CO) and nitric oxide (NO) on the phosphorylation and intracellular redistribution of vasodilator-stimulated phosphoprotein (VASP), a critical actin motor protein required for cell migration that also controls vasodilation and platelet aggregation. RESEARCH DESIGN AND METHODS— We examined the effect of donor-released CO and NO in endothelial progenitor cells (EPCs) and platelets from nondiabetic and diabetic subjects and in human microvascular endothelial cells (HMECs) cultured under low (5.5 mmol/l) or high (25 mmol/l) glucose conditions. VASP phosphorylation was evaluated using phosphorylation site-specific antibodies. RESULTS— In control platelets, CO selectively promotes phosphorylation at VASP Ser-157, whereas NO promotes phosphorylation primarily at Ser-157 and also at Ser-239, with maximal responses at 1 min with both agents on Ser-157 and at 15 min on Ser-239 with NO treatment. In diabetic platelets, neither agent resulted in VASP phosphorylation. In nondiabetic EPCs, NO and CO increased phosphorylation at Ser-239 and Ser-157, respectively, but this response was markedly reduced in diabetic EPCs. In endothelial cells cultured under low glucose conditions, both CO and NO induced phosphorylation at Ser-157 and Ser-239; however, this response was completely lost when cells were cultured under high glucose conditions. In control EPCs and in HMECs exposed to low glucose, VASP was redistributed to filopodia-like structures following CO or NO exposure; however, redistribution was dramatically attenuated under high glucose conditions. CONCLUSIONS— Vasoactive gases CO and NO promote cytoskeletal changes through site- and cell type–specific VASP phosphorylation, and in diabetes, blunted responses to these agents may lead to reduced vascular repair and tissue perfusion. American Diabetes Association 2008-09 /pmc/articles/PMC2518501/ /pubmed/18559661 http://dx.doi.org/10.2337/db08-0381 Text en Copyright © 2008, American Diabetes Association https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Complications
Li Calzi, Sergio
Purich, Daniel L.
Chang, Kyung Hee
Afzal, Aqeela
Nakagawa, Takahiko
Busik, Julia V.
Agarwal, Anupam
Segal, Mark S.
Grant, Maria B.
Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes
title Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes
title_full Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes
title_fullStr Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes
title_full_unstemmed Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes
title_short Carbon Monoxide and Nitric Oxide Mediate Cytoskeletal Reorganization in Microvascular Cells via Vasodilator-Stimulated Phosphoprotein Phosphorylation: Evidence for Blunted Responsiveness in Diabetes
title_sort carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes
topic Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518501/
https://www.ncbi.nlm.nih.gov/pubmed/18559661
http://dx.doi.org/10.2337/db08-0381
work_keys_str_mv AT licalzisergio carbonmonoxideandnitricoxidemediatecytoskeletalreorganizationinmicrovascularcellsviavasodilatorstimulatedphosphoproteinphosphorylationevidenceforbluntedresponsivenessindiabetes
AT purichdaniell carbonmonoxideandnitricoxidemediatecytoskeletalreorganizationinmicrovascularcellsviavasodilatorstimulatedphosphoproteinphosphorylationevidenceforbluntedresponsivenessindiabetes
AT changkyunghee carbonmonoxideandnitricoxidemediatecytoskeletalreorganizationinmicrovascularcellsviavasodilatorstimulatedphosphoproteinphosphorylationevidenceforbluntedresponsivenessindiabetes
AT afzalaqeela carbonmonoxideandnitricoxidemediatecytoskeletalreorganizationinmicrovascularcellsviavasodilatorstimulatedphosphoproteinphosphorylationevidenceforbluntedresponsivenessindiabetes
AT nakagawatakahiko carbonmonoxideandnitricoxidemediatecytoskeletalreorganizationinmicrovascularcellsviavasodilatorstimulatedphosphoproteinphosphorylationevidenceforbluntedresponsivenessindiabetes
AT busikjuliav carbonmonoxideandnitricoxidemediatecytoskeletalreorganizationinmicrovascularcellsviavasodilatorstimulatedphosphoproteinphosphorylationevidenceforbluntedresponsivenessindiabetes
AT agarwalanupam carbonmonoxideandnitricoxidemediatecytoskeletalreorganizationinmicrovascularcellsviavasodilatorstimulatedphosphoproteinphosphorylationevidenceforbluntedresponsivenessindiabetes
AT segalmarks carbonmonoxideandnitricoxidemediatecytoskeletalreorganizationinmicrovascularcellsviavasodilatorstimulatedphosphoproteinphosphorylationevidenceforbluntedresponsivenessindiabetes
AT grantmariab carbonmonoxideandnitricoxidemediatecytoskeletalreorganizationinmicrovascularcellsviavasodilatorstimulatedphosphoproteinphosphorylationevidenceforbluntedresponsivenessindiabetes